Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07433777

Reference Intervals With Indirect Methods in Italy

Reference intervals are an essential tool for the clinical interpretation of laboratory test results. Traditionally, these interval are determined using samples from healthy individuals, a process that is resource-intensive, time-consuming, and require the active recruitment of healthy volunteers.

In recent years, due to the increasing availability of electronic health record (EHR) databases and the growing number of laboratory tests, it is possible to determine the reference intervals indirectly. This approach relies on the analysis of routine data acquired in clinical laboratories, eliminating the need for active recruiting healthy subjects and significantly reducing costs. Moreover, the method has the potential to eliminate the selection bias of an ultra-healthy population typical of the direct methods. The indirect methods for determining reference intervals have evolved from simple strategies of isolating the healthy population using sample metadata, to sophisticated statistical models that effectively distinguish normal from pathological distributions. One of the advanced techniques, RefineR, has reached an excellent combination of accuracy, robustness, and computational efficiency, outperforming previous methods. It has been implemented as an open-source R package, facilitating its application in real-world settings.

In recognition of these advantages, the IFCC (International Federation of Clinical Chemistry and Laboratory Medicine), through its Committee on Reference Intervals and Decision Limits (C-RIDL), has promoted the adoption of indirect methods for determining reference intervals, highlighting the advantages of this strategy, including greater speed, lower costs, and the absence of a need to recruit healthy donors.

Furthermore, a recent study has highlighted age-related physiological variations in hemoglobin levels in elderly population. This underscores the need for defining age-specific reference intervals which are currently absent from most laboratory reports, potentially impacting diagnostic accuracy.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

0 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

ASL Bari, Ospedale della Murgia, Altamura, Altamura, Italy

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • no one

Exclusion criteria

  • no one

Treatment and study plan

Primary outcomes

  1. Define indirect reference intervals for complete blood count (CBC) parameters by analyzing large-scale retrospective routine laboratory data.

    Time frame: up to 3 years

Secondary outcomes

  1. Assess regional differences by comparing results across 10 Italian regions.

    Time frame: up to 3 years

    Statistical heterogeneity will be assessed using Cochran's Q test, and I squared index

  2. Establish age- and sex-specific reference intervals

    Time frame: up to 3 years

  3. Evaluate inter-instrument variations by considering results obtained from different analytical platforms.

    Time frame: up to 3 years

    Statistical heterogeneity will be assessed using Cochran's Q test, and I squared index

Study contacts

Contact information is provided by the study sponsor or research team.

Fabio Del Ben

CONTACT

[email protected]

0434659101

Sponsors and collaborators

Lead sponsor

Centro di Riferimento Oncologico - Aviano

Other

Registry information

Acronym: REFIND-IT

Important dates

Study start
2025
Primary completion
2028
Study completion
2028
First posted
Feb 25, 2026
Registry last updated
Feb 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.